<< Read Full Article
<< Read Full Article
ImClone 'Eager' for Erbitux Data Release
- Loading Comments...
Since I featured ImClone Systems(IMCL Quote) in my weekend Biotech Stock Mailbag just over two weeks ago, the biotech stock has taken a hit.
ImClone was expected to be the big news at the American Society of Clinical Oncology annual meeting, but its stock has now fallen from $47 to $42.
So what happened, you ask? Let's review with a litte hypothetical Q&A. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,307.96 | 1,090.64 | 2,137.05 | 32.25 |
Oil *
75.87
|
|
DOWN
156.44
|
DOWN
19.99
|
DOWN
39.00
|
DOWN
0.54
|
10 Yr
3.22%
SPDR Gold
113.61
|
|
-1.50%
|
-1.80%
|
-1.79%
|
-1.65%
|
Data delayed 20 minutes |


Connect with TheStreet